Charles Peter Kirol, the Chief Operating Officer of $PTON, sold 20,633 shares of the company on 07-16-2025 for an estimated $131,822. We received data on the trade from a recent SEC filing. This was a sale of approximately 36.5% of their shares of this class of stock. Following this trade, they now own 35,877 shares of this class of $PTON stock.
$PTON Insider Trading Activity
$PTON insiders have traded $PTON stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $PTON stock by insiders over the last 6 months:
- JENNIFER CUNNINGHAM COTTER (Chief Content Officer) has made 0 purchases and 5 sales selling 647,104 shares for an estimated $4,698,695.
- ELIZABETH F CODDINGTON (Chief Financial Officer) has made 0 purchases and 6 sales selling 433,339 shares for an estimated $3,341,321.
- ANDREW S RENDICH (Chief Supply Chain Officer) has made 0 purchases and 3 sales selling 163,498 shares for an estimated $1,526,078.
- NICK V. CALDWELL (Chief Product Officer) has made 0 purchases and 4 sales selling 230,701 shares for an estimated $1,521,977.
- DION C. SANDERS (Chief Commercial Officer) has made 0 purchases and 2 sales selling 236,354 shares for an estimated $1,516,333.
- SAQIB BAIG (Chief Accounting Officer) has made 0 purchases and 5 sales selling 91,491 shares for an estimated $739,339.
- CHARLES PETER KIROL (Chief Operating Officer) sold 20,633 shares for an estimated $131,822
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PTON Hedge Fund Activity
We have seen 221 institutional investors add shares of $PTON stock to their portfolio, and 189 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 31,637,067 shares (-65.0%) from their portfolio in Q1 2025, for an estimated $199,946,263
- FMR LLC added 14,570,614 shares (+135.4%) to their portfolio in Q1 2025, for an estimated $92,086,280
- DME CAPITAL MANAGEMENT, LP removed 5,519,279 shares (-52.5%) from their portfolio in Q1 2025, for an estimated $34,881,843
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 4,940,422 shares (+29.4%) to their portfolio in Q1 2025, for an estimated $31,223,467
- D. E. SHAW & CO., INC. removed 3,113,559 shares (-16.9%) from their portfolio in Q1 2025, for an estimated $19,677,692
- COOPER CREEK PARTNERS MANAGEMENT LLC added 3,014,473 shares (+inf%) to their portfolio in Q1 2025, for an estimated $19,051,469
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 2,863,111 shares (-39.6%) from their portfolio in Q1 2025, for an estimated $18,094,861
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PTON Analyst Ratings
Wall Street analysts have issued reports on $PTON in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Macquarie issued a "Outperform" rating on 05/13/2025
- Truist Securities issued a "Buy" rating on 04/28/2025
- B of A Securities issued a "Buy" rating on 04/15/2025
- Canaccord Genuity issued a "Buy" rating on 03/14/2025
To track analyst ratings and price targets for $PTON, check out Quiver Quantitative's $PTON forecast page.
$PTON Price Targets
Multiple analysts have issued price targets for $PTON recently. We have seen 9 analysts offer price targets for $PTON in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- Paul Golding from Macquarie set a target price of $10.0 on 05/13/2025
- Eric Sheridan from Goldman Sachs set a target price of $7.0 on 05/09/2025
- Dana Telsey from Telsey Advisory Group set a target price of $8.0 on 05/09/2025
- Youssef Squali from Truist Securities set a target price of $11.0 on 04/28/2025
- Lauren Schenk from Morgan Stanley set a target price of $4.0 on 04/17/2025
- Curtis Nagle from B of A Securities set a target price of $9.5 on 04/15/2025
- Doug Anmuth from JP Morgan set a target price of $7.0 on 04/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
